BUY Zydus Lifesciences Limited — Sumeet Bagadia, Choice Broking
bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Intraday)28 Aug 2026, 8:00 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·27 Aug · today
1 other SEBI-registered advisor has an active intraday BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·27 Aug · today
Zydus Lifesciences Share Price In Focus After Macquarie Maintains Outperform Rating. Here's Why
NewsNdtv-Profit·27 Aug · yesterday
Zydus Lifesciences Shares Tick Higher On USFDA Nod For Ascorbic Aid Injection
NewsNdtv-Profit·21 Aug · 6d ago
Zydus Lifesciences gets USFDA approval for generic Ascorbic Acid Injection
NewsCnbc-Tv18·21 Aug · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

